Evidence map›Paper›PMID 41392331›Full record

ReviewmAbs2026

Targeted dual selection to optimize transposon stable pool generation of multispecifics.

Julie Johnston, Sonja Tierson, Yuyan Xu, Kalie Mix, Yj Jane Guo, Serhan Zenger, David Reczek, Dietmar Hoffmann, Brian Hall, Virginia Brophy

Abstract readReview
In one paragraph

Review in mAbs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julie JohnstonSanofi US, Large Molecule Research, Cambridge, MA, USA.ORCID 0009-0005-6464-2656
Sonja TiersonSanofi US, Large Molecule Research, Cambridge, MA, USA.
Yuyan XuSanofi US, Large Molecule Research, Cambridge, MA, USA.
Kalie MixSanofi US, Large Molecule Research, Cambridge, MA, USA.ORCID 0000-0002-2836-5744
Yj Jane GuoSanofi US, Large Molecule Research, Cambridge, MA, USA.
Serhan ZengerSanofi US, Large Molecule Research, Cambridge, MA, USA.
David ReczekSanofi US, Large Molecule Research, Cambridge, MA, USA.
Dietmar HoffmannSanofi US, Large Molecule Research, Cambridge, MA, USA.
Brian HallSanofi US, Large Molecule Research, Cambridge, MA, USA.
Virginia BrophySanofi US, Large Molecule Research, Cambridge, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing knowledge around disease states has led to opportunities within research to make designer molecules with improved specificity and broader efficacy. These next-generation molecules frequently take advantage of multispecific targeting and controlled mechanisms of action by utilizing four unique peptide chains as seen in many bispecific or trispecific antibodies. However, with all the opportunities these multispecifics offer, their increased biological complexities come with increased challenges during expression and purification to produce high-quality material. Lower yields accompanied with a high degree of mispairing after the initial capture purification step are often limiting factors. Developing new methods for stable pool expression can offer a strong advantage for progressing these molecules through research toward development. Here, we implemented optimized stable cell pools using targeted dual selection (TDS), a novel approach that combines specified selective pressure with transposon-guided semi-targeted gene integration. By utilizing key analytical data obtained during early-stage high-throughput transient productions, we can predict improved vector configurations for the generation of optimized TDS stable pools. We demonstrate that this design can improve molecule quality at the initial capture purification step in two Y-shaped bispecific molecules and two cross-over dual variable trispecific molecules by achieving up to four-fold increase in protein of interest yields while maintaining product quality. Use of this strategy in research can enable simplified purification strategies as well as increased production yields required for successful and timely project progression.

Indexed as

Antibodies, BispecificDNA Transposable ElementsSingle-Chain AntibodiesAnimalsCHO CellsCricetulusHumansAntibodies, BispecificDNA Transposable ElementsSingle-Chain Antibodiesbispecific antibodydual selectionStable cell pooltargeted dual selectiontrispecific antibody

Identifiers

PMID41392331
PMCPMC12710902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.